For the treatment of central hypogonadism (i.e., hypogonadotropic hypogonadism), gonadotropic factors (LH and FSH) offer the potential to improve fertility in cases where this aspect is the primary therapeutic aim. The gene discussed is BRD2; the disease is hypogonadotropic hypogonadism.